版本:
中国

BRIEF-Sunesis Pharmaceuticals provides update on EU marketing app for vosaroxin

March 22 Sunesis Pharmaceuticals Inc

* Sunesis pharmaceuticals announces submission of responses to ema day 180 list of outstanding issues for marketing authorization application for vosaroxin

* Sunesis pharmaceuticals inc - "anticipating a chmp decision by mid-year"

* Sunesis pharmaceuticals - continue to work to qualify "best pharma partner" to work with us on european market launch of vosaroxin in h2 of 2017 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐